Interestingly, a selective α7 nAChR agonist has been shown to improve rat social recognition memory and to reduce tau hyperphosphorylation [59] suggesting that nAChR agonists may also slow down tau pathology in AD. Here, CHRNA7 is linked to Alzheimer disease.